AstraZeneca Vaxzevria COVID-19 Vaccine from Germany
Vaxzevria uses chimpanzee adenovirus vector expressing SARS-CoV-2 spike for immunity. Retail multi-dose vials qualify under HTS 3002.15.00 immunological products.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Shake well before dose; silicone-free syringes required
• TTS (thrombosis) risk labeling mandatory
• Live vector elements may trigger 3002.30 review